September 19, 2025 a 07:43 am
JNJ: Fundamental Ratio Analysis - Johnson & Johnson
Johnson & Johnson has a stable footprint in the healthcare segment, consistently showing resilience and potential for steady growth. Despite facing industry challenges, its diversified product portfolio positions it well for sustained performance. Investors may find JNJ attractive for its strong brand and market presence.
Fundamental Rating
Johnson & Johnson's fundamental rating depicts a robust profile, highlighted by satisfactory scores in crucial financial metrics. The following table provides insights into various rating categories and their assessed scores.
| Category | Score | Score Bar |
|---|---|---|
| Discounted Cash Flow | 4 | |
| Return on Equity | 5 | |
| Return on Assets | 5 | |
| Debt to Equity | 1 | |
| Price to Earnings | 2 | |
| Price to Book | 2 |
Historical Rating
Historical ratings indicate that Johnson & Johnson has retained a consistent evaluation over the recent term. Below, the current and past scores are displayed.
| Date | Overall Score | DCF | ROE | ROA | Debt/Equity | P/E | P/B |
|---|---|---|---|---|---|---|---|
| 2025-09-18 | 3 | 4 | 5 | 5 | 1 | 2 | 2 |
| Previous | 0 | 4 | 5 | 5 | 1 | 2 | 2 |
Analyst Price Targets
Analysts' price targets provide insights into potential stock movements, reflecting a unanimous evaluation in Johnson & Johnson’s market outlook.
| High | Low | Median | Consensus |
|---|---|---|---|
| 162 | 162 | 162 | 162 |
Analyst Sentiment
The sentiment among analysts indicates a balanced view towards holding JNJ shares, with a notable inclination towards buying suggestions.
| Recommendation | Count | Distribution Bar |
|---|---|---|
| Strong Buy | 0 | |
| Buy | 16 | |
| Hold | 18 | |
| Sell | 3 | |
| Strong Sell | 0 |
Conclusion
Johnson & Johnson maintains a strong presence in the healthcare industry, with steady financial performance indicated by its ratings. The stock exhibits low volatility with stable price targets, appealing to risk-averse investors. Despite some debt concerns, its overall portfolio and consistent market demand stabilize its outlook. With a 'Hold' consensus from analysts, investors may find JNJ a viable long-term investment.